Related Experiment Video
Updated: Jun 13, 2026

An Iodide-Yellow Fluorescent Protein-Gap Junction-Intercellular Communication Assay
Published on: February 1, 2019
Gap junctions and connexins as therapeutic targets in cancer
Mustapha Kandouz1, Gerald Batist
1Wayne State University, Department of Pathology, 5101 Cass Avenue, Chemistry Building, Detroit, Michigan 48202, USA. ag1764@wayne.edu
Importance Of The Field:
Connexins (Cxs) and gap junctional intercellular communications (GJICs) play roles in cancer development, growth and metastasis. Experimental studies suggest that targeting Cxs may be a novel technique, either to inhibit tumor cell growth directly or to sensitize to various therapies.
Areas Covered In This Review:
A brief introduction to the role of Cxs in cancer. The focus is mainly on data available in the literature regarding therapeutic aspects.
What The Reader Will Gain:
This article reviews the various strategies that take advantage of gap junctions and connexins to eliminate cancer cells, including use of the bystander effect (BE) in gene therapy, the effect of connexins on chemosensitization, the role of apoptotic processes and interactions with the microenvironment. Attempts to restore connexin expression at the transcriptional and post-transcriptional levels are described, as well as promising strategies recently explored. The potential and limitations of the approaches are discussed.
Take Home Message:
Connexins have multiple facets, singly, in hemichannel complexes, in gap junctions or interacting with different proteins. The regulation of their expression is not fully resolved and selective manipulation of Cxs expression is therefore a challenge. Although the therapeutic potential of connexins is undeniable, more effort is needed to study the regulation and functions of these proteins.
Insights
Targeting connexins (Cxs) and gap junctional intercellular communications (GJICs) offers novel cancer therapies. Restoring Cxs expression and leveraging their functions show promise for eliminating cancer cells and enhancing treatment efficacy.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Connexins (Cxs) and gap junctional intercellular communications (GJICs) are implicated in cancer progression.
- Targeting Cxs presents a novel strategy for cancer treatment, potentially inhibiting tumor growth or sensitizing cells to therapy.
Purpose of the Study:
- To review therapeutic strategies involving connexins and gap junctions in cancer treatment.
- To explore the role of Cxs in gene therapy, chemosensitization, apoptosis, and microenvironment interactions.
Main Methods:
- Literature review focusing on therapeutic aspects of Cxs in cancer.
- Analysis of strategies to restore connexin expression (transcriptional and post-transcriptional).
Main Results:
- Connexins facilitate cancer cell elimination through bystander effects, chemosensitization, and modulation of apoptosis.
- Strategies to restore connexin expression and leverage their functions are being explored.
- The potential and limitations of these connexin-based therapeutic approaches are discussed.
Conclusions:
- Connexins exhibit diverse roles in cancer, acting individually, in complexes, or interacting with other proteins.
- Selective manipulation of Cxs expression remains challenging due to unresolved regulatory mechanisms.
- Further research into connexin regulation and function is crucial to fully realize their therapeutic potential.
Related Concept Videos
Gap Junctions
Gap Junctions
Overview of Cell-Cell Junctions
Occluding or Tight Junctions
Tight...
Overview of Cell-Cell Junctions
Occluding or Tight Junctions
Tight...
Contact-dependent Signaling
Gap Junctions
In animal cells, gap junctions are formed...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

